NEW YORK, May 12, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer of Intercept, will present at the 2021 RBC Capital Markets Global Healthcare Conference on Wednesday, May 19, 2021 at 4:50 p.m. ET.
A live webcast of the event will be available on the investor page of Intercept’s website at http://ir.interceptpharma.com. An audio archive of the webcast will also be available on Intercept’s website for approximately two weeks.
About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.
CONTACT
For more information about Intercept, please contact:
Investor inquiries: investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
Source: Intercept Pharmaceuticals, Inc.
HealthArc's unified remote care management platform integrates with athenahealth'sEHR to automate clinical documentation, enhance patient…
NEW YORK, Nov. 27, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape…
VICTORIA, BC / ACCESSWIRE / November 27, 2024 / AI/ML Innovations Inc. ("AI/ML" or the…
TORONTO, ON / ACCESSWIRE / November 27, 2024 / Theralase® Technologies Inc. (" Theralase® "…
Renowned expert Dr. Rubinstein to train practitioners on new BOTOX® technique for smoother neck contours…
GRAND RAPIDS, MI / ACCESSWIRE / November 27, 2024 / The American Association of Medical…